Fig. 5 | Scientific Reports

Fig. 5

From: Integrated spatial and single cell transcriptomics identifies PRKDC as a dual prognostic biomarker and therapeutic target in hepatocellular carcinoma

Fig. 5

Analysis of the association between PRKDC and clinical feature in HCC. (A) Expression of PRKDC across different tumor grades in HCC. (B) Expression of PRKDC across clinical stages of HCC. (C) Analysis of the correlation between PRKDC and its role in promoting or slowing down aging marker. (D) Gistic2 score of copy number. (E) Percentage of FGL, FGG, and FGA in PRKDC expression subsets for specific tumors. (F) Spearman correlation between copy number variation score and gene expression level. (G) Differences in PRKDC expression in different copy number variation types. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns > 0.05.

Back to article page